The Defense Health Agency (DHA) intends to award a sole source bridge contract to QUIDELORTHO SALES COMPANY, LLC for the provision of analyzers, assays, reagents, and consumables to the 633rd Medical Group at Langley-Eustis Air Force Base in Hampton, VA. The contract will include two Integrated System Cost Per Reportable Chemistry Analyzers, test equipment, and associated power ware, as well as all validation supplies and reagents. The contractor will also provide support, including equipment repairs, labor, travel, and materials, to keep both units operational 24 hours a day, seven days a week.
• The contract has a period of performance from 2 December 2025 through 30 September 2026, with a 6-month option period.
• The contractor will provide troubleshooting assistance, as requested, 24 hours a day, seven days a week.
• The estimated count of various tests, such as acetaminophen, albumin, and alkaline phosphatase, is provided.
• Capability statements are due by 2:00 PM EST, 10 November 2025, and should be submitted via email as a Microsoft Word or Adobe PDF attachment.